In this Technology Networks interview, Irene De Biase, MD, PhD, a member of the CAP Biochemical and Molecular Genetics Committee, discusses recent progress in biomarker discovery, including the shift toward multiomic approaches. “For instance, three months into 2025, and there are already almost 300 publications using proteomics in various cohorts of patients with diabetes mellitus,” said Dr. De Biase.
For the full article click here: Advances in Biomarker Discovery and Analysis